The Science & Methodology Behind the Platform
The 5 Pillar Framework is CerebroLab’s integrative model for understanding how interconnected dysfunction across anatomical, vascular, immune, and metabolic systems drives neurodegeneration, and help determine where intervention can make a difference.
Homeostatic Brain Health —
5 Pillars of Neurodegeneration Centered on Pathophysiological Dysfunction
Dysregulation of the brain’s biomechanical system is a complex, multifactorial pathogenesis. Homeostatic modification and optimization necessitates an integrative therapeutic paradigm. Effective interventions require coordinated modulation across molecular, cellular, and musculoskeletal (MSK) levels.
This framework identifies five core, interconnected pathophysiological pillars through which homeostatic dysfunction contributes to neurodegenerative pathogenesis. It integrates anatomical, mechanical, vascular, immune, and metabolic consequences.
Clinical Relevance —
The CerebroLab Framework is a Model for:
- →EVALUATING CHRONIC SUBCLINICAL MUSCULOSKELETAL DYSFUNCTION IN EARLY-STAGE NEURODEGENERATION
- →INFORMING THERAPEUTIC STRATEGIES TARGETING ALIGNMENT, DRAINAGE, AND INFLAMMATION
- →UNDERSTANDING IDIOPATHIC OR ATYPICAL NEURODEGENERATION WITH BRAINSTEM FEATURES
The 5 Pillar Framework —
The Diagnostics and Therapeutic Methods are organized into 4 categories:
MULTIPLE HUMAN STUDIES | META-ANALYSES | GUIDELINE SUPPORTED
HUMAN TRIALS OR STRONG OBSERVATIONAL | MECHANISTIC SUPPORT
EARLY HUMAN DATA OR STRONG ANIMAL | MECHANISTIC EVIDENCE
LIMITED PILOT OR CASE-SERIES DATA
Research Links —
The Academic Foundation for the Framework
01
GLYMPHATIC & DETOXIFICATION FAILURE
Impaired cerebrospinal fluid (CSF)–interstitial fluid exchange leads to accumulation of neurotoxic proteins and metabolites.
Loss of astrocytic aquaporin-4 (AQP4) polarization disrupts directional glymphatic flow and accelerates amyloid-β accumulation (Simon et al., 2022).
Meningeal lymphatic–glymphatic coupling is essential for CNS waste clearance; disruption worsens protein aggregation (Louveau et al., 2017).
Glymphatic dysfunction precedes tau pathology, indicating clearance failure is an early event in Alzheimer’s disease progression (Yuying Jiao et al., 2025).
Arterial stiffness, reduced pulsatility, and venous outflow obstruction mechanically impair glymphatic influx and efflux (Benveniste & Nedergaard, 2021).
02
CEREBROVASCULAR DYSFUNCTION (NVU, BBB, GLYCOCALYX)
Breakdown of the neurovascular unit (NVU) impairs cerebral perfusion, blood–brain barrier (BBB) integrity, and nutrient delivery.
NVU dysfunction and BBB breakdown occur prior to cognitive decline in Alzheimer’s disease, suggesting vascular injury precedes amyloid deposition (Sweeney et al., 2019).
Endothelial dysfunction and loss of the endothelial glycocalyx reduce nitric oxide bioavailability, increase permeability, and promote neuroinflammation (Zlokovic, 2011).
Vertebrobasilar insufficiency and jugular venous congestion lead to chronic cortical–brainstem hypoxia and impaired waste clearance (Benjamin et al., 2025).
Endothelial senescence and inflammatory SASP signaling have been demonstrated in ALS vasculature (Jingyuan Ya et al., 2024).
03
BIOMECHANICAL DYSFUNCTION
Craniocervical instability and mechanical strain disrupt brainstem signaling, CSF dynamics, venous drainage, and autonomic regulation.
Craniocervical junction instability and brainstem compression alter CSF pulsatility and neural conduction (Michael F. Flanagan, 2015).
Mechanical compromise affects cranial nerves IX–XII, contributing to dysautonomia, dysphagia, respiratory instability, and postural fatigue (Ross Hauser et al., 2025).
Loss of vagal tone impairs anti-inflammatory signaling and gut–brain communication (Mlaak Rob et al., 2025).
Functional neuroimaging demonstrates early brainstem connectivity abnormalities in Parkinson’s and Alzheimer’s disease (Arianna Sala et al., 2017).
Mechanical and vascular microtrauma prime microglia toward exaggerated inflammatory responses (Norden et al., 2014).
04
NEUROINFLAMMATION & IMMUNE DYSFUNCTION
Chronic innate immune activation drives synaptic toxicity, neuronal loss, and propagation of neurodegeneration.
Mechanical and vascular microtrauma prime microglia toward exaggerated inflammatory responses (Norden et al., 2014).
BBB disruption exposes CNS antigens to peripheral immunity, sustaining chronic inflammation (Huang et al., 2020).
Disease-associated microglia (DAM), MHC-II+, and interferon-reactive phenotypes correlate with distinct neurodegenerative stages (Yi-Hsuan Cheng et al., 2025).
Persistent TLR4 and NLRP3 inflammasome activation promotes neurotoxicity and disease progression (Junling Yang et al., 2020).
Viral immune priming, including HERV-K activation, accelerates inflammatory cascades in ALS and related disorders (Paul Dembny et al., 2019).
05
BIOENERGETIC & METABOLIC COLLAPSE
Mitochondrial failure and oxidative stress reduce neuronal resilience and amplify vulnerability to upstream insults.
Impaired glucose and lipid metabolism leads to synaptic energy failure and neuronal dysfunction (Pratishtha Chatterjee et al., 2020).
Deficient NFE2L2 (NRF2) nuclear translocation weakens antioxidant defenses across AD, PD, and ALS (Emilia Zgorzynska et al., 2021; Elisa Navarro et al., 2024).
Excess reactive oxygen species (ROS) damage mitochondrial DNA, proteins, and membranes (Eui-Hwan Choi et al., 2024).
GLP-1 receptor agonists reduce amyloid processing, enhance antioxidant enzymes (MnSOD), and improve mitochondrial function in preclinical models (Ayush Gandhi et al., 2025; Niklas Reich et al., 2022).
For more in-depth information about the CerebroLab Methodology and Framework, please download our informational PDF:
Information PDF